Skip to main content
OpenTrials
Completed

NCT Number: NCT03123367

Evaluation of the Nella Women's Care Line

Evaluation of the Nella Women's Care Line

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Research Site

Portland, Oregon, 97209, United States

About this study

The Nella Women's Care Line is being studied in women undergoing a gynecological exam and other gynecological procedures that require visibility and access to the cervix.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

General inclusion criteria (applies to all study groups):

  • Subject is female
  • Subject is 18 - 65 years of age, inclusive, at the time of consent
  • Subject is undergoing a gynecological examination (as defined above) as part of their regular clinical care
  • Subject has undergone one or more prior gynecological exams
  • Subject is willing and able to provide written informed consent
  • Subject is able and willing to perform the functions required by the study protocol

General exclusion criteria (applies to all study groups):

  • Subject has undergone hysterectomy
  • Subject has a known history of allergies to latex or plastics
  • Subject is pregnant
  • Subject is post-partum (≤ 12 weeks)
  • Subject has had an induced or spontaneous abortion in the prior 12 weeks
  • Subject has an active gynecologic complaint that, in the opinion of the clinician, would confound study results
  • Subject has dyspareunia
  • Subject has a known history of vulvodynia such as vulvular vestibular syndrome
  • Subject has a known history of vaginismus
  • Subject has a planned surgical procedure along with the gynecological exam
  • Subject is under incarceration
  • Subject is unable to provide written informed consent

Device specific inclusion criteria:

In addition to the general inclusion, the subject must meet all device specific criteria associated with their assignment group. Below are device-specific criteria. There is no device-specific exclusion criterion.

Nella VuSleeve (Group 1) inclusion:

  • Subject has a BMI ≥ 30 and/or 3 or more vaginal births

NellaSpec (Group 2), Nella NuSpec (Group 3), and Nella Insert (Group 4) inclusion:

  • Subject has a BMI < 35

Treatment and study plan

Group 1: Nella VuSleeve

Device

Sleeve

Group 2: Nella NuSpec

Device

Speculum

Group 3: NellaSpec

Device

Speculum

Group 4: Nella Insert

Device

Sleeve

Primary outcomes

  1. Technical Feasibility

    Time frame: Day of Exam or Procedure

    Cervical visualization and access

Secondary outcomes

  1. Safety

    Time frame: Day of Exam or Procedure

    Number of Adverse Events (AEs)

Sponsors and collaborators

Lead sponsor

Ceek Enterprises

Industry

Registry information

Official study title

An Evaluation of the Safety and TechnIcal Feasibility Of the NelLa Women's Care Line for Female Gynecological ExaminaTions and Procedures (VIOLET)

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Apr 21, 2017
Registry last updated
Mar 16, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.